Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Nov 09, 2026
TickeronGET DAILY SIGNALS
Why Is Turning Point Brands (TPB) Stock Down -7.42% Today?

Why Is Turning Point Brands (TPB) Stock Down -7.42% Today?

Key Takeaways

  • TPB shares fell 7.42% to about $60.99, down from a prior close of $65.88.
  • The primary catalyst was a third-quarter earnings report that showed strong sales growth but a steep decline in profitability.
  • Net income fell 81.4% year over year, and adjusted EBITDA dropped 41.3%, driven by sharply higher sales and marketing spending.
  • Revenue beat expectations at $151.1 million, and Modern Oral nicotine pouch sales more than doubled, but margin compression dominated the market reaction.
  • Traders are watching whether the company's reaffirmed full-year guidance can restore confidence in its profitability trajectory.
  • For deeper data, explore Price Targets, Earnings, and Forecast pages.
  • Discover how AI trading systems are navigating this market on the Trending AI Robots page.

Opening Summary

Turning Point Brands, Inc. (TPB), a manufacturer and marketer of branded consumer products including Zig-Zag rolling papers, Stoker's moist snuff, and FRE modern oral nicotine pouches, saw its stock slide sharply in Monday's session. Shares were down 7.42% to roughly $60.99, compared with a prior closing price of $65.88, confirming a decisive downward move on heavy investor scrutiny of the company's latest quarterly results. The sell-off came despite a top-line revenue beat, as markets focused instead on collapsing profitability and rising spending.

Earnings Beat on the Top Line, but Profit Slump

The immediate trigger for the decline was the company's third-quarter 2026 report. TPB posted net sales of $151.1 million, a 27.0% increase from the prior-year period and ahead of consensus estimates. Adjusted diluted earnings per share came in at $0.41, well above the roughly $0.20 consensus, giving the headline numbers a superficially positive appearance.

Beneath the surface, however, the picture was far less favorable. Net income attributable to the company plunged 81.4% to $3.9 million, down from $21.1 million a year earlier, while adjusted diluted EPS of $0.41 represented a steep decline from $1.05 in the same quarter last year. Adjusted EBITDA contracted 41.3% to $18.4 million. Investors appeared to weigh the deterioration in underlying profitability more heavily than the revenue acceleration, prompting the earnings-driven sell-off.

Rising Marketing Spend Compresses Margins

A central factor behind the profit decline was a dramatic increase in operating costs. Selling, general, and administrative expenses rose 69.1% to $75.3 million, reflecting aggressive investments in sales and marketing to build distribution and consumer engagement for the FRE and ALP nicotine pouch brands. While that spending helped drive Modern Oral gross sales up 114.2% to $93.9 million, it came at the expense of near-term margins, a trade-off that appeared to unnerve investors concerned about the pace and duration of the spending ramp.

Mixed segment performance compounded the pressure. The Stoker's segment posted a 52.0% increase in net sales to $113.8 million, powered by triple-digit growth in Modern Oral, while the Zig-Zag segment saw net sales decline 15.5% to $37.3 million. The divergent results underscored that the company's growth is increasingly concentrated in a single, highly competitive category.

Market Context and Trading Activity

The move in TPB reflected a stock-specific, earnings-driven reaction rather than broad market weakness. The decline followed an earnings release that beat revenue and adjusted EPS estimates, yet the shares still traded decisively lower, a sign that investors were recalibrating expectations around profitability and the sustainability of the company's aggressive investment posture. Technical support levels came under pressure as the stock gapped below its recent trading range, with the prior session's close of $65.88 quickly giving way during intraday selling.

What Comes Next for TPB

Looking ahead, the company reaffirmed its full-year 2026 guidance, targeting Modern Oral gross sales of $330 million to $350 million, Modern Oral net sales of $260 million to $270 million, and adjusted EBITDA of $70 million to $80 million. The key question for TPB is whether its heavy spending in the nicotine pouch category will translate into durable market share gains and eventual margin expansion, or whether elevated costs will continue to weigh on earnings. Traders will be monitoring distribution expansion for FRE and ALP, any signs of moderation in marketing spend, and the trajectory of the legacy Zig-Zag segment. Competitive dynamics in the rapidly growing modern oral category and broader consumer discretionary sentiment remain additional sources of uncertainty.

Trending AI Robots

Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in the curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a range of approaches to explore. To see which automated strategies are currently leading the market, visit the Trending AI Robots page and explore the available options.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TPB

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


TPB's RSI Indicator ascending out of oversold territory

The RSI Oscillator for TPB moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 25 of the 31 cases the stock moved higher. This puts the odds of a move higher at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TPB as a result. In 55 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for TPB just turned positive on October 07, 2026. Looking at past instances where TPB's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.

TPB moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TPB crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.

Following a +5.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where TPB advanced for three days, in 231 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 56 cases where TPB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

TPB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TPB entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. TPB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.071) is normal, around the industry mean (-7.297). P/E Ratio (28.154) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.048) is also within normal values, averaging (3.595). Dividend Yield (0.005) settles around the average of (0.060) among similar stocks. P/S Ratio (2.701) is also within normal values, averaging (2.780).

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 57.21B. The market cap for tickers in the group ranges from 99 to 308.42B. PM holds the highest valuation in this group at 308.42B. The lowest valued company is AHII at 99.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was -7%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -25%. ISPR experienced the highest price growth at 15%, while XXII experienced the biggest fall at -62%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was -40%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was 11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 51
Price Growth Rating: 59
SMR Rating: 73
Profit Risk Rating: 68
Seasonality Score: 45 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of tobacco products

Industry Tobacco

Industry
Tobacco
Address
5201 Interchange Way
Phone
+1 502 778-4421
Employees
484
Web
https://www.turningpointbrands.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
CRWV stock surged +58% over the past 30 days, driven by major AI partnerships including a $21 billion expanded deal with Meta and multi-year agreements with Anthropic and Jane Street. Over the past quarter, shares rose +42%, reflecting analyst upgrades, strong revenue backlog growth to $66.8 billion, and sustained AI infrastructure demand.
IREN stock surged +56% over the past 30 days, driven primarily by the announcement of a $625 million acquisition of Mirantis to bolster AI cloud capabilities and the energization of its Sweetwater 1 data center. Over the past quarter, shares are up +31%, reflecting a recovery from earlier volatility tied to Q2 earnings miss and Bitcoin price fluctuations, fueled by the company's pivot to AI infrastructure.